Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 5
1964 7
1965 2
1966 2
1967 6
1968 6
1969 17
1970 11
1971 11
1972 13
1973 17
1974 23
1975 21
1976 23
1977 14
1978 19
1979 19
1980 35
1981 43
1982 25
1983 50
1984 73
1985 56
1986 49
1987 118
1988 129
1989 152
1990 177
1991 202
1992 216
1993 248
1994 292
1995 279
1996 362
1997 371
1998 399
1999 376
2000 520
2001 498
2002 532
2003 633
2004 647
2005 738
2006 732
2007 824
2008 710
2009 711
2010 742
2011 853
2012 871
2013 955
2014 999
2015 915
2016 950
2017 914
2018 819
2019 774
2020 800
2021 855
2022 845
2023 803
2024 246

Text availability

Article attribute

Article type

Publication date

Search Results

20,851 results

Results by year

Filters applied: . Clear all
Page 1
High-risk prostate cancer-classification and therapy.
Chang AJ, Autio KA, Roach M 3rd, Scher HI. Chang AJ, et al. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. Nat Rev Clin Oncol. 2014. PMID: 24840073 Free PMC article. Review.
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease. However, the current definitions of high-risk prostate cancer include a heterogeneous group of patients with a range of prognoses. ...This Review critically evaluates the existi …
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease. However, the current definitions of high-ris …
Microbiota and prostate cancer.
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Rizzo A, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):1058-1065. doi: 10.1016/j.semcancer.2021.09.007. Epub 2021 Sep 15. Semin Cancer Biol. 2022. PMID: 34536504 Review.
Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main causes of cancer-related death worldwide. ...However, few data are available regarding the interactions between prostate cancer and microbi …
Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main causes …
Diagnostic and Therapeutic Strategies for Prostate Cancer.
Nguyen-Nielsen M, Borre M. Nguyen-Nielsen M, et al. Semin Nucl Med. 2016 Nov;46(6):484-490. doi: 10.1053/j.semnuclmed.2016.07.002. Epub 2016 Sep 3. Semin Nucl Med. 2016. PMID: 27825428 Review.
Prostate cancer (PC) is a major disease that affects men's health worldwide. ...This article is a short review of current diagnostic and therapeutic strategies for the care and management of prostate cancer in Denmark....
Prostate cancer (PC) is a major disease that affects men's health worldwide. ...This article is a short review of current diagnostic …
[Locally advanced prostate cancer. Definition, diagnosis and treatment.].
Mayor de Castro J, Caño Velasco J, Aragón Chamizo J, Andrés Boville G, Herranz Amo F, Hernández Fernández C. Mayor de Castro J, et al. Arch Esp Urol. 2018 Mar;71(3):231-238. Arch Esp Urol. 2018. PMID: 29633943 Free article. Review. Spanish.
Prostate cancer is a disease that presents a wide spectrum from low aggressiveness localized to disseminated cancer. Locally advanced prostate cancer (LAPC) is a particularly difficult to manage phase of this spectrum. ...
Prostate cancer is a disease that presents a wide spectrum from low aggressiveness localized to disseminated cancer. Locally advanced …
Prostate cancer immunotherapy.
Mitsogiannis I, Tzelves L, Dellis A, Issa H, Papatsoris A, Moussa M. Mitsogiannis I, et al. Expert Opin Biol Ther. 2022 May;22(5):577-590. doi: 10.1080/14712598.2022.2027904. Epub 2022 Jan 16. Expert Opin Biol Ther. 2022. PMID: 35037527 Review.
INTRODUCTION: Medical treatment for prostate cancer (PC) targets hormonal pathways used by malignant cells. ...ARTICLE HIGHLIGHTS: Intense research performed on immunotherapy for prostate cancer.Vaccine therapy with sipuleucel-T, the only approved immunothera …
INTRODUCTION: Medical treatment for prostate cancer (PC) targets hormonal pathways used by malignant cells. ...ARTICLE HIGHLIG …
Cancer overdiagnosis: a biological challenge and clinical dilemma.
Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, Kramer BS. Srivastava S, et al. Nat Rev Cancer. 2019 Jun;19(6):349-358. doi: 10.1038/s41568-019-0142-8. Nat Rev Cancer. 2019. PMID: 31024081 Free PMC article. Review.
Since the implementation of screening tests for certain cancers (for example, breast and prostate cancers), a spike in incidence of in situ and early-stage cancers has been observed, but a link to reduction in cancer-specific mortality has not been as clear. ...In cancers …
Since the implementation of screening tests for certain cancers (for example, breast and prostate cancers), a spike in incidence of i …
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
Hofman MS, Hicks RJ, Maurer T, Eiber M. Hofman MS, et al. Radiographics. 2018 Jan-Feb;38(1):200-217. doi: 10.1148/rg.2018170108. Radiographics. 2018. PMID: 29320333 Review.
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity to its active extracellular center have emerged as a potential new diagnostic standard of re …
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is overexpressed in prostate cancer. Radiolabel …
Mucinous and secondary tumors of the prostate.
Osunkoya AO. Osunkoya AO. Mod Pathol. 2018 Jan;31(S1):S80-S95. doi: 10.1038/modpathol.2017.132. Mod Pathol. 2018. PMID: 29297488 Free article. Review.
The primary mucinous tumors of the prostate include mucinous (colloid) adenocarcinoma of the prostate, prostatic adenocarcinoma with mucinous features, and mucinous adenocarcinoma of the prostatic urethra (mucin-producing urothelial-type adenocarcinoma …
The primary mucinous tumors of the prostate include mucinous (colloid) adenocarcinoma of the prostate, prostatic adenoc …
Inflammation and Prostate Cancer.
Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Tewari AK, et al. Adv Exp Med Biol. 2018;1095:41-65. doi: 10.1007/978-3-319-95693-0_3. Adv Exp Med Biol. 2018. PMID: 30229548 Review.
Evidence gathered from genetic, epidemiological and molecular pathological studies suggest that inflammation plays a crucial role at various stages of prostatic carcinogenesis and tumor progression. These include initiation, promotion, malignant conversion, i …
Evidence gathered from genetic, epidemiological and molecular pathological studies suggest that inflammation plays a crucial role at various …
Mesenchymal tumors of the prostate.
McKenney JK. McKenney JK. Mod Pathol. 2018 Jan;31(S1):S133-142. doi: 10.1038/modpathol.2017.155. Mod Pathol. 2018. PMID: 29297486 Free article. Review.
These may be either benign or malignant and can arise within the prostate gland or in adjacent tissues. This review covers prostatic stromal proliferations (prostatic stromal tumor of uncertain malignant potential and stromal sarcoma), so …
These may be either benign or malignant and can arise within the prostate gland or in adjacent tissues. This review covers …
20,851 results
You have reached the last available page of results. Please see the User Guide for more information.